219 related articles for article (PubMed ID: 11134128)
21. The characteristics of remnant lipoproteins in the fasting and postprandial plasma.
Nakajima K; Nakano T; Tokita Y; Nagamine T; Yatsuzuka S; Shimomura Y; Tanaka A; Sumino H; Nara M; Machida T; Murakami M
Clin Chim Acta; 2012 Jul; 413(13-14):1077-86. PubMed ID: 22433787
[TBL] [Abstract][Full Text] [Related]
22. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma.
Leary ET; Wang T; Baker DJ; Cilla DD; Zhong J; Warnick GR; Nakajima K; Havel RJ
Clin Chem; 1998 Dec; 44(12):2490-8. PubMed ID: 9836716
[TBL] [Abstract][Full Text] [Related]
24. High level of plasma remnant-like particle cholesterol may predispose to development of hypertension in normotensive subjects.
Kasahara A; Adachi H; Hirai Y; Enomoto M; Fukami A; Yoshikawa K; Esaki E; Yokoi K; Ogata K; Tsukagawa E; Obuchi A; Yoshimura A; Nakamura S; Imaizumi T
Am J Hypertens; 2013 Jun; 26(6):793-8. PubMed ID: 23403840
[TBL] [Abstract][Full Text] [Related]
25. Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy.
Perotti M; Caumo A; Brunani A; Cambiaghi N; Casati M; Scacchi M; Perra S; Rocco C; Mancia G; Grassi G; Cavagnini F; Pincelli AI
Clin Endocrinol (Oxf); 2012 Nov; 77(5):721-7. PubMed ID: 22519803
[TBL] [Abstract][Full Text] [Related]
26. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
Granér M; Kahri J; Nakano T; Sarna SJ; Nieminen MS; Syvänne M; Taskinen MR
Eur J Clin Invest; 2006 Nov; 36(11):764-70. PubMed ID: 17032343
[TBL] [Abstract][Full Text] [Related]
27. Fasting remnant lipoproteins can predict postprandial hyperlipidemia.
Nagata T; Sugiyama D; Kise T; Tsuji S; Ohira H; Sato I; Yamamoto M; Kohsaka H; Kawano S; Yamashita S; Ishikawa Y; Fujioka Y
Lipids Health Dis; 2012 Oct; 11():146. PubMed ID: 23110373
[TBL] [Abstract][Full Text] [Related]
28. A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load.
Ai M; Tanaka A; Shimokado K; Ohtani R; Inazu A; Kobayashi J; Mabuchi H; Nakano T; Nakajima K
Ann Clin Biochem; 2009 Nov; 46(Pt 6):457-63. PubMed ID: 19641010
[TBL] [Abstract][Full Text] [Related]
29. [Impact of high remnant-like lipoproteins on the function of peripheral arterial endothelium in patients with hyperlipidemia and normolipidemia: estimation using Doppler flow analysis].
Funada J; Sekiya M; Otani T; Watanabe K; Akutsu H
J Cardiol; 2001 May; 37(5):267-76. PubMed ID: 11392896
[TBL] [Abstract][Full Text] [Related]
30. Improvement of endothelial dysfunction is mediated through reduction of remnant lipoprotein after statin therapy in patients with coronary artery disease.
Nakamura T; Uematsu M; Yoshizaki T; Kobayashi T; Watanabe Y; Kugiyama K
J Cardiol; 2020 Mar; 75(3):270-274. PubMed ID: 31500961
[TBL] [Abstract][Full Text] [Related]
31. Determinants of postprandial triglyceride and remnant-like lipoproteins in type 2 diabetes.
Tan KC; Tso AW; Ma OC; Pang RW; Tam S; Lam KS
Diabetes Metab Res Rev; 2005; 21(2):209-14. PubMed ID: 15386805
[TBL] [Abstract][Full Text] [Related]
32. Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipase.
Nakajima K; Tokita Y; Sakamaki K; Shimomura Y; Kobayashi J; Kamachi K; Tanaka A; Stanhope KL; Havel PJ; Wang T; Machida T; Murakami M
Clin Chim Acta; 2017 Feb; 465():45-52. PubMed ID: 27986550
[TBL] [Abstract][Full Text] [Related]
33. Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.
Tan KC; Tso AW; Tam SC; Pang RW; Lam KS
Diabet Med; 2002 Nov; 19(11):944-8. PubMed ID: 12421432
[TBL] [Abstract][Full Text] [Related]
34. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies.
Ballantyne CM; Bays HE; Philip S; Doyle RT; Braeckman RA; Stirtan WG; Soni PN; Juliano RA
Atherosclerosis; 2016 Oct; 253():81-87. PubMed ID: 27596132
[TBL] [Abstract][Full Text] [Related]
35. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
O'Neal DN; Hew FL; Best JD; Alford F
Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
[TBL] [Abstract][Full Text] [Related]
36. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
37. Remnant-like particle cholesterol levels in Korean patients with coronary artery disease and non-insulin dependent diabetes mellitus.
Song J; Park H; Hong SH; Lee HK; Park YB; Kim JQ
Clin Chem Lab Med; 2000 May; 38(5):427-32. PubMed ID: 10952226
[TBL] [Abstract][Full Text] [Related]
38. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS
J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221
[TBL] [Abstract][Full Text] [Related]
39. Resistance exercise but not aerobic exercise lowers remnant-like lipoprotein particle cholesterol in type 2 diabetes: a randomized controlled trial.
Gavin C; Sigal RJ; Cousins M; Menard ML; Atkinson M; Khandwala F; Kenny GP; Proctor S; Ooi TC;
Atherosclerosis; 2010 Dec; 213(2):552-7. PubMed ID: 20870234
[TBL] [Abstract][Full Text] [Related]
40. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
